IP Library › Assignment 027079/0331
Patent Assignment
Reel/Frame 027079/0331

Verified Statement of Foreclosure by Third Party

Recorded: 2011-10-18 Received: 2011-10-18 Pages: 67
Assignors
IMMUNEREGEN BIOSCIENCES, INC.
Executed: 2011-10-03
IR BIOSCIENCES HOLDINGS, INC.
Executed: 2011-10-03
Assignee
ILNS, LLC
101 HUDSON STREET, SUITE 3700, JERSEY CITY, NJ, 07302, UNITED STATES
Covered Properties (65)
Substance P and Analogs Thereof as Adjuvant Therapy for Adoptive Cellular Immunotherapy
Application: 61/286,709 →
Method to Treat Blood Cell Depletion
Application: 12/301,426 →
Methods of Treating Inflammatory and Fibrotic Lung Diseases with Substance P Analogs
Application: 61/252,059 →
Substance P and Analogs Thereof as a Cancer Immunogenic Composition Adjuvant
Compositions and Methods of Using Substance P. Analogs
Methods for Stimulating Fibroblast Proliferation Using Substance P Analogs
Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance P or an analog thereof
Application: 12/220,403 →
Methods for Stimulating Fibroblast Proliferation Using Substance P Analogs
Application: 12/179,418 →
Methods of Treating Blood Cell Depletion
Method of Using Substance P Analogs for Treatment Amelioration of Myelodysplastic Syndrome
Methods of Treating Blood Cell Depletion
Application: 12/179,409 →
Methods and Compositions for Stimulating the Proliferation or Differentiation of Stem Cells with Substance P or an Analog Thereof
Methods and Compositions for Stimulation of Fibroblast Proliferation with Substance P Analogs
Application: 61/047,709 →
Substance P and Analogs Thereof as a Cancer Immunogenic Composition Adjuvant
Application: 61/045,856 →
Method of Using Substance P Analogs in Radiation Oncology
Application: 61/039,860 →
Method of Using Substance P Analogs for Amelioration of Myelodysplastic Syndrome
Application: 61/039,867 →
Methods of Using Substance P and Analogs for Ameliorating Drug Induced Blood Dyscrasias
Application: 61/039,866 →
Methods of Using Substance P Analogs for Stem Cell Growth
Application: 61/038,871 →
Compositions and Methods for Improving the Texture or Appearance of Human Skin with Substance P Analogs
Application: 61/028,774 →
Methods of Ex Vivo Expansion of Bone Marrow Cells Using Substance P Analogs
Application: 61/024,354 →
Substance P and Analogs Thereof as an Immunogenic Composition Adjuvant
Methods and Compositions for Improving the Texture or Appearance of Skin with Substance P, or an Analog Thereof
Application: 61/016,245 →
Methods for Stimulating the Proliferation and/or Differentiation of Stem Cells with Substance P, or an Analog Thereof
Application: 60/983,012 →
Methods of Stimulating or Promoting Fibroblast Proliferation with Substance P or an Analog Thereof
Application: 60/979,769 →
Methods of using Substance P and analogs thereof to promote cell differentiation
Application: 60/997,314 →
Use of substance P analogs as PARP inhibitors
Application: 60/966,948 →
Methods of using substance P and analogs for ameliorating adverse effects of drugs
Application: 60/965,580 →
Prophylactic and Therapeutic Treatment of Avian Influenza Infections in Animals
Substance P and Analogs Thereof as a Vaccine Adjuvant
Application: 60/955,712 →
Method to Stimulate Blood Cells Regeneration Following Non-Lethal Radiation Exposure
Application: 60/952,691 →
Method to Treat Blood Cell Depletion, In Conditions Such As MDS
Application: 60/952,394 →
Method to Treat Blood Cell Depletion
Substance P as an Adjuvant
Application: 60/915,358 →
Prophylactic and Therapeutic Treatment of Mammals for Avian Influenza Virus Infections
Application: 60/915,373 →
Method to Reduce the Risk and/or Severity of Anthrax Infection
Prophylactic and therapeutic treatment of mammals for avian influenza infections
Application: 60/899,004 →
Method to reduce the risk and/or severity of anthrax infection
Application: 60/899,035 →
Substance P as an Adjuvant
Application: 60/885,562 →
Prophylactic and Therapeutic Treatment of Mammals for Avian Influenza Infections
Application: 60/866,901 →
Method to Reduce the Risk and/or Severity of Anthrax Infection
Application: 60/828,723 →
Prophylactic and Therapeutic Treatment of Mammals for Avian Influenza Infections
Application: 60/828,728 →
Prophylactic and therapeutic treatment of mammals for avian influenza infections
Application: 60/837,635 →
Method to treat blood cell depletion
Application: 60/809,391 →
Treatment of Asthma
Method to reduce the risk and/or severity of anthrax infection
Application: 60/781,367 →
Method to reduce the risk and/or severity of anthrax infection
Application: 60/780,825 →
Treatment of Skin Diseases
Prevention of Respiratory Infections in Fowl
Method to Promote Wound Healing
Anti-Aging Effects of Substance P
Inducing and Maintaining Hair Color
Treatment of asthma
Application: 60/667,062 →
Treatment of skin diseases
Application: 60/642,996 →
Prevention of respiratory infections in fowl
Application: 60/641,153 →
Method to promote wound healing
Application: 60/622,015 →
Anti-aging effects of substance P
Application: 60/565,021 →
Acute Respiratory Syndromes
Stimulation of Hair Regrowth
Coated Article with Silicon Nitride Inclusive Layer Adjacent Glass
Application: 10/645,836 →
Amelioration of Effects of Cigarette Smoke
Acute respiratory syndromes
Application: 60/465,266 →
Acute respiratory distress syndrome
Application: 60/462,316 →
Amelioration of effects of cigarette smoke
Application: 60/406,036 →
Prophylactic and Therapeutic Treatment of Avian Influenza Infections in Animals
Application: 12/376,650 →
Prevention of Respiratory Infections In Fowl
Application: 11/794,659 →